相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Validation of a multisubstance online Timeline Followback assessment
Renee Martin-Willett et al.
BRAIN AND BEHAVIOR (2020)
The endocannabinoid system in migraine: from bench to pharmacy and back
Cristina Tassorelli et al.
CURRENT OPINION IN NEUROLOGY (2019)
Time trends in US cannabis use and cannabis use disorders overall and by sociodemographic subgroups: a narrative review and new findings
Deborah S. Hasin et al.
AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE (2019)
The New Runner's High? Examining Relationships Between Cannabis Use and Exercise Behavior in States With Legalized Cannabis
Sophie L. YorkWilliams et al.
FRONTIERS IN PUBLIC HEALTH (2019)
Endocannabinoid System and Migraine Pain: An Update
Rosaria Greco et al.
FRONTIERS IN NEUROSCIENCE (2018)
Medicinal Properties of Cannabinoids, Terpenes, and Flavonoids in Cannabis, and Benefits in Migraine, Headache, and Pain: An Update on Current Evidence and Cannabis Science
Eric P. Baron
HEADACHE (2018)
Cannabinoid Delivery Systems for Pain and Inflammation Treatment
Natascia Bruni et al.
MOLECULES (2018)
Cardiovascular Events, Conditions, and Procedures Among People With Episodic Migraine in the US Population: Results from the American Migraine Prevalence and Prevention (AMPP) Study
Dawn C. Buse et al.
HEADACHE (2017)
Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015
Valery L. Feigin et al.
LANCET NEUROLOGY (2017)
Cannabis as a substitute for prescription drugs - a cross-sectional study
James M. Corroon et al.
JOURNAL OF PAIN RESEARCH (2017)
Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches
Martin Andersson et al.
HARM REDUCTION JOURNAL (2017)
The Use of Cannabis for Headache Disorders
Bryson C. Lochte et al.
CANNABIS AND CANNABINOID RESEARCH (2017)
Transdermal cannabidiol reduces inflammation and pain-related behaviours in a rat model of arthritis
D. C. Hammell et al.
EUROPEAN JOURNAL OF PAIN (2016)
GBD 2015: migraine is the third cause of disability in under 50s
Timothy J. Steiner et al.
JOURNAL OF HEADACHE AND PAIN (2016)
Effects of Medical Marijuana on Migraine Headache Frequency in an Adult Population
Danielle N. Rhyne et al.
PHARMACOTHERAPY (2016)
Sex Differences in Cannabis Use and Effects: A Cross-Sectional Survey of Cannabis Users
Carrie Cuttler et al.
CANNABIS AND CANNABINOID RESEARCH (2016)
Clinical Endocannabinoid Deficiency Reconsidered: Current Research Supports the Theory in Migraine, Fibromyalgia, Irritable Bowel, and Other Treatment-Resistant Syndromes
Ethan B. Russo
CANNABIS AND CANNABINOID RESEARCH (2016)
Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013
Deborah S. Hasin et al.
JAMA PSYCHIATRY (2015)
A safer alternative: Cannabis substitution as harm reduction
Nicholas Lau et al.
DRUG AND ALCOHOL REVIEW (2015)
Chronic migraine
Todd J. Schwedt
BMJ-BRITISH MEDICAL JOURNAL (2014)
Triptans and ergot alkaloids in the acute treatment of migraine: similarities and differences
Peer C. Tfelt-Hansen
EXPERT REVIEW OF NEUROTHERAPEUTICS (2013)
Nabilone for the treatment of medication overuse headache: results of a preliminary double-blind, active-controlled, randomized trial
Luigi Alberto Pini et al.
JOURNAL OF HEADACHE AND PAIN (2012)
Cannabis as an Adjunct to or Substitute for Opiates in the Treatment of Chronic Pain
Philippe Lucas
JOURNAL OF PSYCHOACTIVE DRUGS (2012)
ICHD-3: What Changes Do We Need Regarding Migraine?
Gian Camillo Manzoni et al.
CURRENT PAIN AND HEADACHE REPORTS (2011)
Who Are Medical Marijuana Patients? Population Characteristics from Nine California Assessment Clinics
Craig Reinarman et al.
JOURNAL OF PSYCHOACTIVE DRUGS (2011)
Alterations of the endocannabinoid system in an animal model of migraine: Evaluation in cerebral areas of rat
R. Greco et al.
CEPHALALGIA (2010)
The endocannabinoid system and migraine
Rosaria Greco et al.
EXPERIMENTAL NEUROLOGY (2010)
Comparative topical anti-inflammatory activity of cannabinoids and cannabivarins
Aurelia Tubaro et al.
FITOTERAPIA (2010)
Agreement of self-reported migraine with ICHD-II criteria in the Women's Health Study
M. Schuerks et al.
CEPHALALGIA (2009)
Degradation of endocannabinoids in chronic migraine and medication overuse headache
L. M. Cupini et al.
NEUROBIOLOGY OF DISEASE (2008)
Endocannabinoids in platelets of chronic migraine patients and medication-overuse headache patients: relation with serotonin levels
Cristiana Rossi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Endocannabinoids in chronic migraine: CSF findings suggest a system failure
Paola Sarchielli et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Migraine and risk of cardiovascular disease in women
Tobias Kurth et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Anandamide is able to inhibit trigeminal neurons using an in vivo model of trigeminovascular-mediated nociception
S Akerman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors
S Akerman et al.
BRITISH JOURNAL OF PHARMACOLOGY (2004)
Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment:: a meta-analysis of 53 trials
MD Ferrari et al.
LANCET (2001)
Advances in pharmacological treatment of migraine
HC Diener et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2001)
Marijuana Craving Questionnaire: development and initial validation of a self-report instrument
SJ Heishman et al.
ADDICTION (2001)
分享论文
